|
Baseline
|
Treatment
|
Follow-up
|
---|
Day 0
|
Day 7
|
Week 2
|
Week 4
|
Week 8
|
Week 12
|
Week 16
|
---|
V1
|
V2
|
V3
|
V4
|
V5
|
V6
|
V7
|
---|
Sign informed consent
|
×
| | | | | | |
Randomization
|
×
| | | | | | |
Medical history
|
×
| | | | | | |
Intervention
|
×
|
×
|
×
| | | | |
Primary outcome
| | | | | | | |
Treatment failure rate
| |
×
|
×
|
×
| | | |
All-cause mortality
| |
×
|
×
|
×
|
×
|
×
|
×
|
Secondary outcomes
| | | | | | | |
Length of hospitalization
| |
×
|
×
|
×
| | | |
Overall survival
| |
×
|
×
|
×
|
×
|
×
|
×
|
Acute exacerbation rate
| | | | |
×
|
×
|
×
|
Intubation rate
| |
×
|
×
|
×
|
×
|
×
|
×
|
mMRC
|
×
|
×
|
×
|
×
| | |
×
|
SGRQ-I
|
×
|
×
|
×
|
×
| | |
×
|
Arterial blood gas analysis
|
×
|
×
|
×
|
×
| | | |
- Abbreviations: mMRC Modified British Medical Research Council, SGRQ-I The St George’s Respiratory Questionnaire for Idiopathic Pulmonary Fibrosis